This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Real-world evidence lets us see how HIV medicines work in real life, helping HCP...
Presiding over the upward trajectory of Eli Lilly over the last eight years is p...
Novo Nordisk is rolling out a new national marketing campaign for its GLP-1 jugg...
At the American Academy of Dermatology's annual meeting this weekend, Bristol My...
As the US healthcare landscape continues to evolve, 2025 is set to bring signifi...
Astellas Pharma and Yaskawa Electric Corporation formalized a development deal s...
Otsuka America Pharmaceutical is continuing its work to provide support to and a...
Otsuka America Pharmaceutical is continuing its work to provide support to and a...
How biologics, cold chain management and early collaboration are transforming dr...
In 2024, Bayer chief Bill Anderson’s total compensation fell about 21% to 8.84 m...
AstraZeneca is preparing to talk to the FDA about a potential new use of its imm...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
While Novo Nordisk has been operating in rare disease for some 45 years, the fie...
Vertex is putting marketing might behind its push into kidney conditions, profil...
A Texas court has rejected a request by compounders to extend their ability to m...
U.S. President Donald Trump has issued a memorandum directing federal agencies t...
If confirmed, Johns Hopkins surgeon Martin Makary, M.D., would take the reins at...
After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a co...
Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled pat...
After reviewing additional clinical data, England's drug-price watchdog NICE has...
Moderna sued Pfizer and BioNTech over three patents protecting its COVID-19 work...
While the ebb and flow of mpox outbreaks may have taken a toll on Bavarian Nordi...
In this tracker, Fierce Pharma is recording the regulatory progress of in-market...
A federal district court in Texas will allow Novo Nordisk to intervene in a laws...